Label: MAYINGLONG BEZORNIL HEMORRHOIDAL- calamine, petrolatum, phenylephrine hydrochloride ointment

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated August 28, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients
    Calamine 10.5%
    Petrolatum 79.25%
    Phenylephrine hydrochloride 0.25%

  • PURPOSE

    Purpose
    Hemorrhoidal (anorectal) astringent/protectant
    Hemorrhoidal (anorectal) protectant
    Hemorrhoidal (anorectal) vasoconstrictor

  • INDICATIONS & USAGE

    Uses
    temporarily helps relieve:
    anorectal burning, itching, and discomfort associated with hemorrhoids
    temporarily:
    reduces the swelling associated with irritated hemorrhoidal tissue and other anorectal disorders
    shrinks hemorrhoidal tissue
    protects inflamed perianal skin and irritated areas

  • WARNINGS

    Warnings
    For rectal use only

  • ASK DOCTOR

    Ask a doctor before use if you have
    heart disease
    high blood pressure
    thyroid disease
    diabetes
    difficulty in urination due to enlargement of the prostate gland

  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are
    presently taking a prescription drug for high blood pressure or depression

  • WHEN USING

    When using this product
    in case of bleeding; consult a doctor promptly
    do not exceed the recommended daily dosage unless directed by a doctor
    do not use with an applicator if the introduction of the applicator into the rectum causes
    additional pain. Consult a doctor promptly.

  • STOP USE

    Stop use and ask a doctor if
    condition worsens
    symptoms do not improve within 7 days

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • DOSAGE & ADMINISTRATION

    Directions
    adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
    For external hemorrhoids, apply a small amount of ointment directly to the affected area up to 4 times daily.
    FOR INTRARECTAL USE (internal hemorrhoids): Attach applicator to tube. Lubricate applicator well, then gently insert applicator into the rectum. Squeeze a small amount (2 g) of the ointment into the rectum. Remove and discard used applicator. Apply to the affected area up to 4 times daily.
    children under 12 years of age: consult a doctor.

  • STORAGE AND HANDLING

    Other information
    keep container tightly closed
    store at room temperature 20 - 25º C (68 - 77º F)
    do not use if the physical properties of this product have changed

  • INACTIVE INGREDIENT

    Inactive ingredients
    Amber, lanolin, pearl, and sodium borate.

  • QUESTIONS

    Questions or comments?
    (888) 221-3496 M-F 9 am to 5 pm

  • PRINCIPAL DISPLAY PANEL

    MAYINGLONG BEZORNIL HEMORRHOIDAL OINTMENT  NDC 30803-001-01  0.353 oz (10 g)IMAGE OF CARTON

  • INGREDIENTS AND APPEARANCE
    MAYINGLONG BEZORNIL HEMORRHOIDAL 
    calamine, petrolatum, phenylephrine hydrochloride ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:30803-001
    Route of AdministrationTOPICAL, RECTAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE10.4 g  in 100 g
    FERRIC OXIDE RED (UNII: 1K09F3G675) (FERRIC OXIDE RED - UNII:1K09F3G675) FERRIC OXIDE RED0.05 g  in 100 g
    PHENYLEPHRINE HYDROCHLORIDE (UNII: 04JA59TNSJ) (PHENYLEPHRINE - UNII:1WS297W6MV) PHENYLEPHRINE HYDROCHLORIDE0.25 g  in 100 g
    PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM79.25 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    AMBER (UNII: 70J9Z0J26P)  
    LANOLIN (UNII: 7EV65EAW6H)  
    SODIUM BORATE (UNII: 91MBZ8H3QO)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:30803-001-0110 g in 1 TUBE, WITH APPLICATOR
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart34608/28/2013
    Labeler - MAYINGLONG PHARMACEUTICAL GROUP CO LTD (526823828)
    Establishment
    NameAddressID/FEIBusiness Operations
    MAYINGLONG PHARMACEUTICAL GROUP CO LTD526823828manufacture(30803-001)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!